Black Hawk Acquisition Corporation

BKHA ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item Aug 2026 May 2026 Feb 2026 Nov 2025 Aug 2025 May 2025 Feb 2025 Nov 2024
Operating Activities
Net Income $1.1M $88.9K $139.8K $-3.8K $154.4K $520.5K $658.4K $751.7K
Depreciation & Amortization — — — — — — — —
Depreciation — — — — — — — —
Amortization — — — — — — — —
Stock-Based Compensation — — — — — — — —
Net Cash from Operating Activities $-113.5K $-236.6K $-109.5K $-100.5K $-107.9K $-278.6K $-163.3K $-59.0K
Investing Activities
Capital Expenditures — — — — — — — —
Business Acquisitions — — — — — — — —
Net Cash from Investing Activities $-450.0K $-450.0K $-600.0K — — — — —
Financing Activities
Dividends Paid — — — — — — — —
Stock Repurchases — — — — — — — —
Net Cash from Financing Activities $563.9K $519.8K $848.4K — — — — $0
Net Change in Cash — — — — — — — —
Free Cash Flow — — — — — — — —
← Newer Page 1 of 2 Older →